Evidence map›Paper›PMID 40415581›Full record

ArticleEuropean psychiatry : the journal of the Association of European Psychiatrists2025

Metabolic syndrome and its components are associated with lengths of stay in a psychiatric hospital: Results from a Swiss psychiatric cohort and first-episode psychosis patients.

Nermine Laaboub, Setareh Ranjbar, Séverine Crettol, Nicolas Ansermot, Frederik Vandenberghe, Carole Grandjean, Marianna Piras, Julien Elowe, Martin Preisig, Armin Von Gunten and 2 more

Abstract read
In one paragraph

Article in European psychiatry : the journal of the Association of European Psychiatrists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nermine LaaboubUnit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0000-0001-8029-2418
Setareh RanjbarCenter for Psychiatric Epidemiology and Psychopathology, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0000-0002-0238-2976
Séverine CrettolUnit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0000-0003-3790-7194
Nicolas AnsermotUnit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0000-0001-8350-9416
Frederik VandenbergheUnit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0000-0002-8964-2047
Carole GrandjeanUnit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0009-0002-0460-9182
Marianna PirasUnit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0009-0001-5579-0199
Julien EloweService of Adult Psychiatry North-West, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0000-0002-9538-331X
Martin PreisigCenter for Psychiatric Epidemiology and Psychopathology, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0000-0001-5689-4259
Armin Von GuntenService of Old Age Psychiatry, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
Philippe ConusService of General Psychiatry, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
Chin Bin EapUnit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, https://ror.org/05a353079Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.ORCID 0000-0002-5439-0230

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to limited inpatient care resources and high healthcare expenditures, understanding factors that affect lengths of stay (LOS) is highly relevant. We aimed to investigate associations between metabolic disturbances and LOS in a psychiatric hospital and to identify other clinical and sociodemographic LOS predictors.

methodsPatients admitted to one of the units of the general psychiatric or psychogeriatric departments between January 1, 2007 and December 31, 2020, were included. Metabolic disturbances (i.e., the metabolic syndrome and its five components) were defined using the International Diabetes Federation definition. Cox frailty regression models with time-varying coefficients were used to investigate the association between metabolic disturbances and LOS. Hazard ratios (HR) >1 and HR < 1 indicated the relative likelihood of shorter and extended LOS, respectively.

resultsA total of 7,771 patients for 16,959 hospital stays throughout 14 years of follow-up were included. Central obesity (HR = 0.82; 95% confidence interval [CI] = [0.76-0.89]), hyperglycemia (HR = 0.83; 95% CI = [0.78-0.89]), hypertriglyceridemia (HR = 0.87; 95% CI = [0.80-0.92]), and the metabolic syndrome (HR = 0.76; 95% CI = [0.70-0.82]) were associated with an increased risk of extended LOS in the psychiatric hospital, while underweight (HR = 1.30, 95% CI = [1.09-1.56]) and HDL hypocholesterolemia (HR = 1.10, 95% CI = [1.03-1.18]) were associated with a higher likelihood of shorter LOS. In first-episode psychosis patients, hypertriglyceridemia (HR = 0.82; 95% CI = [0.67-0.99]) and hypertension (HR = 0.76, 95% CI = [0.58-0.99]) were associated with extended LOS when considering all stays, while no association was found when considering the first stay per patient.

conclusionFuture studies should determine whether better metabolic monitoring and treatment of metabolic disturbances can contribute to reducing LOS.

Indexed as

Hospitals, PsychiatricLength of StayMetabolic SyndromePsychotic DisordersAdultCohort StudiesFemaleHumansMaleMiddle AgedSwitzerlandlengths of staymetabolic disturbancesmetabolic syndromepsychiatry

Identifiers

PMID40415581
PMCPMC12303775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.